Analyst picks & changes

Agouron Pharmaceuticals Inc.

(AGPH), La Jolla, Calif.

Business: Infectious diseases/AIDS

Montgomery Securities analyst David Crossen said that data on AGPH's

Viracept

protease inhibitor in triple combination therapy with

AZT

and

3TC

was comparable to

Read the full 379 word article

How to gain access

Continue reading with a
two-week free trial.